Administration patterns of magnesium sulphate for women with preeclampsia and immediate newborn outcomes in Kawempe National Referral Hospital-Uganda: a cohort study
Abstract Background Preeclampsia is the second leading cause of maternal death in Uganda. WHO recommends using magnesium sulphate (MgSO4) to prevent and treat preeclampsia with severe features (PEC) and eclampsia. MgSO4 is used to prevent eclampsia and treat women who experience an eclamptic convuls...
Saved in:
| Main Authors: | Mariam Birungi, Jane Nakibuuka, Mark Kaddumukasa, Josephine Najjuma, Christopher J. Burant, Shirley Moore, Carol Blixen, Elly T. Katabira, Martha Sajatovic, Scovia Nalugo Mbalinda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | BMC Pregnancy and Childbirth |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12884-024-06915-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk Factors Associated with Low Apgar Scores in Pregnancies Complicated by Severe Preeclampsia: A Case–Control Study
by: Yunxia Wang, et al.
Published: (2024-12-01) -
Umbilical arterial blood lactate as predictor of early neonatal outcome and evaluation of intrapartum asphyxia
by: Olufemi M. Badmus, FWACS, et al.
Published: (2024-10-01) -
Self-Management Intervention for Reducing Epilepsy Burden Among Adult Ugandans with Epilepsy (SMART-U): Randomised Clinical Trial Protocol
by: Mbalinda SN, et al.
Published: (2024-11-01) -
Maternal and neonatal outcome among women with early-onset preeclampsia and late-onset preeclampsia
by: Luthfi Rahman, et al.
Published: (2024-12-01) -
The use of antibiotic-loaded calcium sulphate beads in debridement, antibiotics, and implant retention (DAIR) for periprosthetic infections: a retrospective comparative cohort on outcome
by: Irene Katharina Sigmund, et al.
Published: (2024-11-01)